» Articles » PMID: 34929672

Incidence Estimates of Acute Q Fever and Spotted Fever Group Rickettsioses, Kilimanjaro, Tanzania, from 2007 to 2008 and from 2012 to 2014

Abstract

Q fever and spotted fever group rickettsioses (SFGR) are common causes of severe febrile illness in northern Tanzania. Incidence estimates are needed to characterize the disease burden. Using hybrid surveillance-coupling case-finding at two referral hospitals and healthcare utilization data-we estimated the incidences of acute Q fever and SFGR in Moshi, Kilimanjaro, Tanzania, from 2007 to 2008 and from 2012 to 2014. Cases were defined as fever and a four-fold or greater increase in antibody titers of acute and convalescent paired sera according to the indirect immunofluorescence assay of Coxiella burnetii phase II antigen for acute Q fever and Rickettsia conorii (2007-2008) or Rickettsia africae (2012-2014) antigens for SFGR. Healthcare utilization data were used to adjust for underascertainment of cases by sentinel surveillance. For 2007 to 2008, among 589 febrile participants, 16 (4.7%) of 344 and 27 (8.8%) of 307 participants with paired serology had Q fever and SFGR, respectively. Adjusted annual incidence estimates of Q fever and SFGR were 80 (uncertainty range, 20-454) and 147 (uncertainty range, 52-645) per 100,000 persons, respectively. For 2012 to 2014, among 1,114 febrile participants, 52 (8.1%) and 57 (8.9%) of 641 participants with paired serology had Q fever and SFGR, respectively. Adjusted annual incidence estimates of Q fever and SFGR were 56 (uncertainty range, 24-163) and 75 (uncertainty range, 34-176) per 100,000 persons, respectively. We found substantial incidences of acute Q fever and SFGR in northern Tanzania during both study periods. To our knowledge, these are the first incidence estimates of either disease in sub-Saharan Africa. Our findings suggest that control measures for these infections warrant consideration.

Citing Articles

Derivation and Internal Validation of a Clinical Prediction Model for Diagnosis of Spotted Fever Group Rickettsioses in Northern Tanzania.

Williams R, Brintz B, Nicholson W, Crump J, Moorthy G, Maro V Open Forum Infect Dis. 2025; 12(3):ofaf100.

PMID: 40070814 PMC: 11893975. DOI: 10.1093/ofid/ofaf100.


Comparison of Paired Immunofluorescent Antibody Serology and Real-Time Polymerase Chain Reaction Testing for the Detection of Acute Q Fever among Febrile Patients in Kilimanjaro, Tanzania, 2012-2014.

Rolfe R, Crump J, Maro V, Mmbaga B, Saganda W, Lwezaula B Am J Trop Med Hyg. 2025; 112(3):533-538.

PMID: 39742524 PMC: 11884282. DOI: 10.4269/ajtmh.23-0860.


Risk Factors for Spotted Fever Group Rickettsioses in Kilimanjaro Region, Tanzania.

Bowhay T, Rubach M, Mendes A, Nicholson W, Perniciaro J, Maze M Open Forum Infect Dis. 2024; 11(12):ofae664.

PMID: 39691286 PMC: 11651152. DOI: 10.1093/ofid/ofae664.


Metagenomic Detection of Bacterial Zoonotic Pathogens among Febrile Patients, Tanzania, 2007-2009.

Rolfe R, Sheldon S, Kingry L, Petersen J, Maro V, Kinabo G Emerg Infect Dis. 2024; 30(8):1599-1608.

PMID: 39043406 PMC: 11286057. DOI: 10.3201/eid3008.240529.


Rickettsia africae infections in sub-Saharan Africa: A systematic literature review of epidemiological studies and summary of case reports.

Zhang E, Kalmath P, Abernathy H, Giandomenico D, Nolan M, Reiskind M Trop Med Int Health. 2024; 29(7):541-583.

PMID: 38813598 PMC: 11216893. DOI: 10.1111/tmi.14002.


References
1.
Njeru J, Henning K, Pletz M, Heller R, Forstner C, Kariuki S . Febrile patients admitted to remote hospitals in Northeastern Kenya: seroprevalence, risk factors and a clinical prediction tool for Q-Fever. BMC Infect Dis. 2016; 16:244. PMC: 4891891. DOI: 10.1186/s12879-016-1569-0. View

2.
Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O . Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ. 2004; 329(7476):1212. PMC: 529364. DOI: 10.1136/bmj.38251.658229.55. View

3.
Vanderburg S, Rubach M, Halliday J, Cleaveland S, Reddy E, Crump J . Epidemiology of Coxiella burnetii infection in Africa: a OneHealth systematic review. PLoS Negl Trop Dis. 2014; 8(4):e2787. PMC: 3983093. DOI: 10.1371/journal.pntd.0002787. View

4.
Cherry C, Denison A, Kato C, Thornton K, Paddock C . Diagnosis of Spotted Fever Group Rickettsioses in U.S. Travelers Returning from Africa, 2007-2016. Am J Trop Med Hyg. 2018; 99(1):136-142. PMC: 6085799. DOI: 10.4269/ajtmh.17-0882. View

5.
van der Hoek W, Sarge-Njie R, Herremans T, Chisnall T, Okebe J, Oriero E . Short communication: prevalence of antibodies against Coxiella burnetii (Q fever) in children in The Gambia, West Africa. Trop Med Int Health. 2013; 18(7):850-3. DOI: 10.1111/tmi.12116. View